Targeting a cell state common to triple‐negative breast cancers-Reference-Cited by-同舟云学术

Targeting a cell state common to triple‐negative breast cancers

Published:2015-02 Issue:2 Volume:11 Page:789
ISSN:1744-4292
Container-title:Molecular Systems Biology
language:en
Short-container-title:Mol Syst Biol

Author:

Muellner Markus K¹,Mair Barbara¹,Ibrahim Yasir²,Kerzendorfer Claudia¹,Lechtermann Hannelore¹,Trefzer Claudia¹,Klepsch Freya¹,Müller André C¹,Leitner Ernestine¹,Macho‐Maschler Sabine³,Superti‐Furga Giulio¹^ORCID,Bennett Keiryn L¹,Baselga José⁴,Rix Uwe⁵,Kubicek Stefan¹,Colinge Jacques¹,Serra Violeta²,Nijman Sebastian MB¹

Affiliation:

1. CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences Vienna Austria

2. Experimental Therapeutics Group Vall d'Hebron Institute of Oncology Barcelona Spain

3. University of Veterinary Medicine Vienna Austria

4. Memorial Sloan‐Kettering Cancer Center New York NY USA

5. H. Lee Moffitt Cancer Center and Research Institute Tampa FL USA

Publisher

EMBO

Subject

Applied Mathematics,Computational Theory and Mathematics,General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,Information Systems

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/msb.20145664

Reference55 articles.

1. STAT3 upregulates the protein expression and transcriptional activity of beta‐catenin in breast cancer;Armanious H;Int J Clin Exp Pathol,2010

2. A Novel Mode of Gleevec Binding Is Revealed by the Structure of Spleen Tyrosine Kinase

3. The protein data bank: A computer-based archival file for macromolecular structures

4. Oat Hay Poisoning

5. A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring potential molecular targets and therapeutic efficacy of beauvericin in triple-negative breast cancer cells;Computational Biology and Chemistry;2024-10

2. Materials, workflows and applications of IMAC for phosphoproteome profiling in the recent decade: A review;TrAC Trends in Analytical Chemistry;2023-01

3. A recent update on small‐molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry‐based proteomic analysis;The FEBS Journal;2022-03-31

4. NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells;Cancers;2022-03-22

5. Turning liabilities into opportunities: Off-target based drug repurposing in cancer;Seminars in Cancer Biology;2021-01